May 17, 2012
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide …MarketWatch (press release)"We are pleased the Phase 3 data presented today showed tapentadol ER was effective at providing pain management for patients with chronic, moderate to severe pain associated with DPN," said Christine Rauschkolb, MD, Ph.D., Vice President and Head of …and more » View full [...]
Read the full article →
May 17, 2012
Distractions Help Cut PainMedPage Today"Our findings strengthen the role of cognitive-behavioral therapeutic approaches in the treatment of pain diseases, as it could be extrapolated that these approaches might also have the potential to alter the underlying neurobiological mechanisms as …and more » View full post on pain management – Google News
Read the full article →